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Abstract
β1 integrin regulates multiple epithelial cell functions by connecting cells with the extracellular matrix (ECM). While β1
integrin-mediated signaling in murine epithelial stem cells is well-studied, its role in human adult epithelial progenitor
cells (ePCs) in situ remains to be defined. Using microdissected, organ-cultured human scalp hair follicles (HFs) as a
clinically relevant model for studying human ePCs within their natural topobiological habitat, β1 integrin-mediated
signaling in ePC biology was explored by β1 integrin siRNA silencing, specific β1 integrin-binding antibodies and
pharmacological inhibition of integrin-linked kinase (ILK), a key component of the integrin-induced signaling cascade.
β1 integrin knock down reduced keratin 15 (K15) expression as well as the proliferation of outer root sheath
keratinocytes (ORSKs). Embedding of HF epithelium into an ECM rich in β1 integrin ligands that mimic the HF
mesenchyme significantly enhanced proliferation and migration of ORSKs, while K15 and CD200 gene and protein
expression were inhibited. Employing ECM-embedded β1 integrin-activating or -inhibiting antibodies allowed to
identify functionally distinct human ePC subpopulations in different compartments of the HF epithelium. The β1
integrin-inhibitory antibody reduced β1 integrin expression in situ and selectively enhanced proliferation of bulge
ePCs, while the β1 integrin-stimulating antibody decreased hair matrix keratinocyte apoptosis and enhanced
transferrin receptor (CD71) immunoreactivity, a marker of transit amplifying cells, but did not affect bulge ePC
proliferation. That the putative ILK inhibitor QLT0267 significantly reduced ORSK migration and proliferation and
induced massive ORSK apoptosis suggests a key role for ILK in mediating the ß1 integrin effects. Taken together,
these findings demonstrate that ePCs in human HFs require β1 integrin-mediated signaling for survival, adhesion,
and migration, and that different human HF ePC subpopulations differ in their response to β1 integrin signaling.
These insights may be exploited for cell-based regenerative medicine strategies that employ human HF-derived
ePCs.
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Introduction
Integrins are transmembrane receptors that link the
extracellular matrix (ECM) environment with intracellular
signaling, thus regulating multiple cell functions such as cell
survival, proliferation, migration, and differentiation [1–3]. 18 α
and 8 β mammalian integrin subunits have been identified so
far, which can assemble to 24 different heterodimers with
different affinities toward specific ECM components [4–7]. The
extracellular binding activity is regulated intracellularly (inside-
out signaling), while extracellular binding of the ECM triggers
signals that are transmitted into the cell (outside-in signaling)
[6,8,9]. When specific ECM ligands bind to the extracellular
region, integrin receptors cluster in the cell membrane and the
cytoplasmic part of the integrin complex sends signals to the
actin cytoskeleton and forms focal adhesions (FAs) [10,11].
Defined ECMs in adult tissues (niches) are likely to be the
first molecular components interacting with stem cells (SCs)
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[12,13]. These niches regulate adult SC-preservation and/or
differentiation and by that regulating the homeostasis of
tissues/organs, like the epidermis and the cyclic hair follicle
(HF) [12,14]. ß1 integrin signaling has long been thought to be
important in murine epidermal and HF epithelial SCs (eSCs)
[15–17]. In the HF, eSCs and partially differentiated epithelial
progenitor cells (ePCs) can give rise to all epithelial cell types
of the hair, the epidermis, and the sebaceous gland and are
mostly found within the HF bulge [18–20]. The eSCs within this
HF compartment [16,21] are slow-cycling, and show
clonogenicity and proliferative capacity [22]. Potential markers
for the epithelial HF SCs include β1 integrin, keratin 15 and 19
(K15, K19), α6 integrin, the transferrin receptor (CD71), p63
and CD34; however there is still considerable debate over how
to distinguish the least committed, slow-cycling eSCs from their
immediate progeny (i.e., rapidly proliferating, but more
committed transit amplifying cells) [23–27].
Previous work has suggested that epithelial cells in human
epidermis with the highest level of α2β1, α3β1 and α5β1
integrin expression show a high colony-forming efficiency
(CFE) [28], and that ß1 integrin signaling is absolutely required
for epidermal and HF maintenance in mice [3]. However, the
role of β1 integrin signaling in human ePC maintenance or
differentiation, namely in human HFs, remains to be clarified,
since the bulge region of human scalp HFs does not express
markedly more ß1 integrin protein than other regions of the
basal layer of the human outer root sheath (ORS) [16,29].
Potential ligands for integrins expressed on HF keratinocytes
are components of the basement membrane (BM) that
separates the HF epithelium from its surrounding
mesenchyme, the connective tissue sheath (CTS). These BM-
associated integrin ligands include collagen IV, laminin-5,
perlecan and nidogen [3,30]. Thus, ORS keratinocytes
(ORSKs) can interact with multiple ECM components of the BM
via α2β1, α3β1, and α6β4 integrins, which are differentially
expressed in distinct regions of the HF [31,32]. α3β1 integrins
connect the actin cytoskeleton to the BM via binding laminin-5,
whereas the α2β1 integrin is found in basal keratinocytes,
where it is thought to mediate cell–cell interactions and BM
attachment via collagens [4,15,32].
On this background, we have further explored the role of β1
integrin-mediated signaling in the human HF epithelium in situ,
exploiting organ-cultured human scalp HFs as an easily
accessible mini-organ that represent a prototypic
neuroectodermal-mesodermal interaction system in which
various ePC populations can be studied within their natural
tissue habitat [29,33,34]. Specifically, we wished to elucidate
the impact of manipulating the outside-in signaling of β1
integrin via different ligands on the maintenance, differentiation
and/or migration of distinct human ePC subpopulations in situ.
This was investigated by ß1 integrin silencing in full-length
human scalp HFs, which permits one to evaluate the role of ß1
integrin in ePCs within their intact human HF SC niche. In
addition, dispase-pretreated organ-cultured adult human scalp
HF epithelium, which lacks normal HF BM and mesenchyme,
was embedded into Matrigel®, since the latter is rich in ECM
components that are also found in the HF’s CTS and BM, such
as laminin, collagen IV, heparin sulfate proteoglycans, entactin,
and growth factors [12,35], with collagen I added for structural
support and for mimicking any signaling input of dermal
collagen. This was done in the absence or presence of
activating or inhibiting ß1 integrin antibodies (see Text S1).
Downstream ß1 integrin-mediated signaling was
pharmacologically disrupted with QLT0267 (DERMIRA,
[36–38]), which was developed as a putative ILK (integrin-
linked kinase) inhibitor, a key adaptor protein that interacts with
the cytoplasmic domains of β1 and β3 integrins and regulates
many cellular processes by connecting ß1 integrin with other




All experiments were performed adhering to the Declaration
of Helsinki Principles, and with the University of Luebeck ethics
committee approval (06-109). HFs were isolated from human
scalp skin obtained from routine face-lift surgery (from 12
female patients aged 19-75 years, mean age 50.2 years) after
written consent.
β1 integrin silencing
In 3 experiments, whole HFs were cut out of human scalp
skin and transfected once with a pool of 3 human β1 integrin-
specific siRNAs (Santa Cruz, sc-35674). HFs treated with
control siRNA conjugated with FITC (Santa Cruz, sc-36869)
served as a scrambled control in comparison to HFs which
were just cultured in transfection medium. After transfection
HFs were maintained in a 6-well-plate with 3ml William’s E
medium (Biochrom) supplemented with 1% L-glutamine
(Invitrogen), 0.02% hydrocortisone (Sigma-Aldrich), 0.1%
insulin (Sigma-Aldrich) and 1% penicillin/streptomycin mixture
(Gibco, [34]). All reagents essential for transfection were
obtained from Santa Cruz Biotechnology (siRNA transfection
reagent, sc-29528; siRNA transfection medium, sc-36868).
Isolation and culturing of human hair follicles in an
extracellular matrix assay
HF epithelium was isolated after dispase-pretreatment (0.1%
(w/v) in William’s E medium without penicillin/streptomycin over
night at 4°C and embedded into an artificial and BM mimicking
ECM system, a mixture of Matrigel® (BD Biosciences) and
collagen I (ratio 1:1) in keratinocyte serum-free medium (K-
SFM). The embedded HFs were cultured over 4 days in the
presence or absence of the two different β1 integrin antibodies
(an activating 12G10 and an inhibiting mAb13 antibody) or in
the presence or absence of the ILK inhibitor QLT0267 in
comparison to standard organ-cultured HFs (in supplemented
William’s E medium) [42].
The concentration of 10µg/ml for 12G10 and mAb13 was
already described as effective and established for HF organ
cultures in a previous study of our lab [29] while the application
of the ILK inhibitor QLT0267 concentration was chosen
empirically. Adapting previous studies [36–38,43,44] which only
describe different concentrations used for QLT0267 in cell
β1 Integrin Controls Epithelial Progenitor Cells
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culture experiments, we chose a high concentration of 100µM
(dissolved in DMSO [Dimethyl sulfoxide]) being most effective
in this complexity of an embedded mini-organ as the HF with its
outgrowing cells. We expected that the inhibitor penetration
into the tissue would be more difficult than into cultured cells.
The scarcity of human HFs available for experimentation
generally prohibits running of dose response studies.
During the culture we analyzed HF cell outgrowth by
measuring the whole area around the HF and the two largest
outgrowth points starting from the hair shaft (HF bulb, upper
HF) every second day.
Immunofluorescence and immunohistochemical
analysis
Cultured whole HFs were cryosectioned (6µm) and
embedded HFs were cryosectioned (8µm). The
immunoreactivity (IR) pattern of endogenous β1 integrin
(12G10, 1:500; kindly given by the Humphries’ lab), keratin 15
(K15) (1:400, Chemicon, CBL), K6 (1:400, Progen), CD200-
biotin (1:25, serotec), ILK (1:100, Epitomics), CD71-PE (1:100,
BD Pharmingen), cleaved caspase 3 (1:400, Cell Signaling),
cortactin-alexa fluor 488 (1:400, Millipore), Ki-67 and TUNEL
were quantified [34]. For the quantification of the IR pattern of
β1 integrin inhibitory and stimulatory antibody treated HFs a
labelling of the primary antibodies, which was not already
coupled with a fluorochrome or signaling molecule (biotin), was
necessary. The primary antibodies against K15 and K6 were
covalently attached with biotin by using the APEX® Antibody
Labeling Kit (Invitrogen, Biotin-XX, cat.no. A10495).
5-ethynyl-2'-deoxyuridine incorporation
A more specific method to detect cell proliferation is the
quantifying of only S-phase active and DNA-synthesizing cells
[45]. By using 5-ethynyl-2'-deoxyuridine (EdU), a terminal
nucleoside analog of thymidine, its incorporation during active
DNA synthesis [46] could be visualized because of its labeling
with a stabile fluorescence dye. The whole method was
performed following the manufacture’s guidelines (Click-iT®
EdU Alexa Fluor® 488 Flow Cytometry Assay Kit, Invitrogen).
Quantitative real-time PCR for expression analysis of
β1 integrin, K15, CD200, and K6
The total RNA of 12 HFs per condition, cultured in William’s
E medium or embedded in the aECM (artificial extracellular
matrix) assay was extracted by using TRIreagent (Applied
Biosystems/Life Technologies) and digested with recombinant
RNase-free DNase-1 (Applied Biosystems) according to the
manufacturer’s protocol. 1 μg of total, isolated RNA was
reverse transcribed into cDNA with High Capacity cDNA kit
(Applied Biosystems) following the manufacturer’s protocol. By
using specific TaqMan primers and probes (Applied
Biosystems, assay IDs: Hs00559595_m1 for human β1
integrin, Hs00267035_m1 for human Keratin 15,
Hs01033303_m1 for human CD200 and Hs01699178_g1 for
human Keratin 6) PCR amplification was performed. As internal
housekeeping gene controls, transcripts of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), peptidylprolyl isomerase
A (PPIA) or β-actin were determined (assay IDs: Hs99999903
for human ACTB, Hs99999904 for human PPIA and
Hs99999905_m1 for human GAPDH). The amount of the
above mentioned transcripts was normalized to those of the
control genes using the ΔCT method.
Protein extraction and Western blot analysis of
integrin-linked kinase
20 HFs were isolated after an over night 0.1% (w/v) dispase
treatment (4°C) and were washed in phosphate buffered saline
(PBS), flash frozen in liquid nitrogen and lysed in buffer
containing 10 mM Tris-HCl, pH 7,2, 2% sodium dodecyl
sulphate (SDS), 1% Triton-X100, 10% Glycerol and 2%
Protease Inhibitor Set I. Later the samples were further
homogenized by using ultra sound (power 60) for 15 seconds.
After a centrifugation the supernatant was taken and protein
concentrations were determined using the Pierce BCA protein
assay kit.
20 µg protein lysates were then separated by electrophoresis
through a 10% SDS gel and transferred to a PVDF
(Polyvinylidene Difluoride) membrane. The membrane was
blocked in 5% non-fat dried milk in tris buffered saline (TBS),
0.05% Tween-20, incubated in primary antibody (ILK 1:2000,
Epitomics, β-actin 1:1000, Santa Cruz) overnight at 4°C,
washed in TBS/0.05% Tween-20, and incubated with
horseradish peroxidase (HRP)-conjugated secondary antibody
(Jackson Immunoresearch Laboratories) for 1h at room
temperature. Secondary antibody was visualized using ECL
(enhanced chemiluminescence) reagent, according to the
manufacturer's instructions (GE Healthcare).
Statistical analyses
All data were given as the mean of normalized data±SEM
(standard error of the mean) and the evaluation of statistical
significance was performed by using GraphPad Prism 5.01
(Graph Pad software, Inc., San Diego, CA, USA). T-test or one-
way ANOVA followed by an appropriate post hoc comparison
(depending on a given Gaussian distribution) was used
specifically.
Results
β1 integrin silencing reduces proliferation and DNA
synthesis in different progenitor cell populations of the
human hair follicle epithelium
β1 integrin is prominently expressed throughout the human
HF BM, including the eSC niche region of the HF [16,17], and
human HF ePCs from the bulge overexpress β1 integrin mRNA
[47,48]. Therefore, we first investigated the overall effects of β1
integrin silencing on human ePC functions in situ within intact,
full-length, organ-cultured human scalp HFs that had been
transfected with a cocktail of three β1 integrin-specific siRNAs
or with scrambled control RNAs, using a standardized method
that had previously been found to be effective [49,50] following
the manufacturer’s guidelines (Santa Cruz). Successful β1
integrin knock down in human anagen scalp HFs was
demonstrated at the mRNA level on day 4 (Figure 1A), yet did
β1 Integrin Controls Epithelial Progenitor Cells
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not change ß1 integrin protein IR in the silenced HFs compared
to controls after 4 days (Figure 1B).
The mammalian HF epithelium harbors different progenitor
cell populations with distinct proliferation capacities, such as
slow-cycling, intermittently proliferating ePC populations in the
Figure 1.  Gene silencing of β1 integrin in normal human hair follicles.  (A) ß1 integrin gene expression was analysed with
qRT-PCR using full-length hair follicles (HFs). At day1 the silencing had a strong influence on the ß1 integrin transcription of HFs,
PCR results on day 4 confirmed a significant silencing. Fold expression of all analyzed genes were normalized to GAPDH. n =2-3
individuals (for RNA extraction 12 HFs/patient were used and cultured over 4 days). (B) The immunoreactivity (IR) pattern of ß1
integrin in the whole HF was analyzed on day4 using the ß1 integrin-activating antibody 12G10. The IR intensity displayed no
differences in the analyzed groups and in the different HF compartments. The control is normalized to 100%. n=17-26 HFs of 3
individuals; representative photos of HF bulbs on day4. (C) β1 integrin silencing caused a significant reduction of Ki-67+ matrix
keratinocytes of anagen HFs (counted below Auber’s line; dotted white line) treated with β1 integrin siRNA compared to the
scrambled control on day4. n=13-16 HFs of 3 individuals. (D) To dissect the proliferation capacity of slow-cycling epithelial
progenitor cells of the HF bulge Ki-67+ cells were counted in rectangles (representative photos). β1 integrin silencing caused a
significant reduction of Ki-67+ cells in the bulb, but also in the HF bulge on day4. n=13-24 HFs of 3 individuals. Red bars=Ki-67,
green bars=TUNEL. (E) By analyzing the proliferating status in a human HF via counting EdU+ cells in our rectangles we could show
the same tendency for proliferation in β1 integrin-mediated signaling as counting Ki-67+ cells in the analyzed HF compartments.
n=2-3 HFs of 1 individual.
White scale bars represent=50µm. All statistical analyses were performed with the one-way ANOVA by appropriate post hoc
comparison (depending on a given Gaussian distribution), mean of normalized data +/- SEM (*p<0.05, **p<0.01, ***p<0.001).
Abbreviation: HKG=housekeeping gene, GAPDH=glyceraldehyde3-phosphate dehydrogenase, ITGβ1 KD=knock down of ß1
integrin, IR=immunoreactivity.
doi: 10.1371/journal.pone.0084356.g001
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bulge versus rapidly proliferating, transit amplifying cells in the
hair matrix [51,52]. Analyzing only anagen VI HFs, quantitative
immunohistomorphometry of the proliferation marker Ki-67
showed that, compared to scrambled control HFs, β1 integrin-
specific silencing significantly reduced the number of Ki-67+
cells (10% less than scrambled control) in the maximally
proliferating hair matrix (Figure 1C), and also significantly
reduced the number of slow-cycling Ki-67+ cells in the HF bulge
(Figure 1D). These results were double-checked by measuring
EdU incorporation, a cell cycle S-phase specific marker to
determine active DNA synthesis [46]. Counting EdU+ cells in
defined reference areas in the HF bulb and HF bulge, the same
proliferation-inhibitory tendency after β1 integrin silencing could
be demonstrated in both HF compartments (Figure 1E, Figure
S2C). Instead, β1 integrin knock down did not significantly
affect apoptosis in the HF bulb, as measured by TUNEL assay
(Figure 1D).
Thus, even though β1 integrin knock down was documented
only on the mRNA level (perhaps due to extended ß1 integrin
protein stability within the human HF), silencing was
functionally effective since it reduced proliferation and DNA
synthesis in both slow-cyling human bulge ePCs and rapidly
proliferating human hair matrix keratinocytes in situ. This
suggests that β1 integrin may indeed operate as an important
niche receptor that regulates proliferation activity in different
ePC populations in the human HF.
β1 integrin-mediated signaling is required for human
epithelial progenitor cell maintenance in situ
To determine if β1 integrin-mediated signaling is needed for
the maintenance and differentiation of ePCs, we analysed the
effects of β1 integrin knock down on the expression of ePC
markers K15 and CD200 [16,53,54] in human HFs in situ.
Initially, i.e. one day after knock down, β1 integrin silencing
even slightly enhanced K15, CD200 and K6 gene expression in
human scalp HFs (Figure 2A,C,E), possibly as a temporary
compensatory phenomenon. Subsequently, however, K15
transcription was significantly reduced 4 days after silencing by
β1 integrin siRNA compared to scrambled controls (Figure 2A).
In the main eSC region, the HF bulge, this was also associated
with a significant reduction of K15 and CD200 protein IR
(Figures 2B,B1-3, Figures 2D,D1-3), suggesting that
uninterrupted ß1 integrin signaling is required to maintain
human HF eSCs within their niche.
We then investigated if β1 integrin silencing impacts on the
expression of K6, which is prominently and constitutively
expressed by differentiated keratinocytes throughout the
human ORS, but not by HF bulge eSCs [55,56] and on CD71
expression, a marker of transit amplifying cells, the immediate
progeny of eSCs [57,58]. After β1 integrin silencing a non-
specific repression of K6 IR in both HF compartments (Figure
2E,F) can be seen and CD71 protein IR was only slightly
reduced (Figure S2A). While ß1 integrin-mediated signaling is
required to preserve the adult ePC pool in adult human HFs, a
major overall differentiation-modulatory impact of β1 integrin
silencing could not be confirmed for K6 and CD71.
ß1 integrin silencing does not alter expression of the
hair follicle bulge immune privilege marker MHC class
Ia
The prominent expression of the immunoinhibitory “no
danger-signal”, CD200 in the HF bulge [59] not only
demarcates ePCs [16,21,53], but also constitutes part of the
relative immune privilege of the HF bulge, which may protect
the HF eSC niche against autoimmune attacks and is
characterized by an extremely low expression of major
histocompatibility complex (MHC) class Ia [21,60,61]. While
CD200 IR in the HF bulge was significantly reduced (Figures
2D,D1-3), β1 integrin silencing did not alter the (already
minimal) MHC Ia IR within the human HF bulge (Figure S2B).
This suggests that intact ß1 integrin signaling is not essential
for the maintenance of the MHC class Ia-based immune
privilege of the human bulge.
β1 integrin ligands enhance human hair follicle
keratinocyte outgrowth in situ
Next, we investigated the influence of ECM ligands of the
human HF mesenchyme (BM, CTS) that are likely to interact
with ß1 integrin. For this purpose, human scalp HFs were
treated with dispase, which cleaves collagen IV and fibronectin
[62,63] to remove the HF BM and CTS. The remaining
denuded HF epithelium was then embedded into an ECM
environment that partially mimics aspects of the native HF
mesenchyme and BM (i.e. Matrigel®, which is rich in the ß1
integrin ligands laminin, collagen IV, heparin sulfate
proteoglycans, entactin, and growth factors [12,35,64],
combined for greater stability with collagen I which represents
the main dermal collagen). Both components were diluted in K-
SFM, which is optimized for the isolation and expansion of
human keratinocytes [65]. The outgrowth of ORSKs from
plated human HF epithelium was measured planimetrically
during three different time points. This demonstrated that only
the HFs embedded into an aECM, consisting of Matrigel® and
collagen I, showed marked ORSK outgrowth of the whole HF
area (Figure 3A,B). This suggests that ECM-mediated
signaling via integrins expressed on ORSKs is indispensable
for ORSK migration in situ.
Interestingly, the addition of anti-β1 integrin antibodies
(namely, the specific ß1 integrin activating [12G10] or inhibiting
[mAb13] antibodies [66,67]) enhanced the ORSK outgrowth
area compared to the dispase-pretreated HF epithelium not
embedded into aECM (“vehicle control”), but it showed
significantly less outgrowth compared to denuded HFs
embedded in aECM. Surprisingly, both activating and inhibiting
ß1 integrin antibodies had very similar stimulatory effects on
the ORSK area outgrowth (of the whole HF) (Figure 3A).
β1 integrin receptor ligands differentially regulate
epithelial cell proliferation and apoptosis in distinct
human hair follicle compartments
Since outside-in signaling via β1 integrin regulates many
fundamental epithelial cell functions [6,68], we sought to
correlate the observed differences in ORSK outgrowth to
proliferation and apoptosis markers. When the dispase-
pretreated HF epithelium embedded in the CTS- and BM-
β1 Integrin Controls Epithelial Progenitor Cells
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mimicking aECM was compared with standard organ-cultured,
but also dispase-pretreated HFs, removal of the BM and CTS
promoted epithelial cell apoptosis in the human HF epithelium
in situ. The contact of dispase-pretreated HFs with the aECM
alone already significantly reduced apoptosis and up-regulated
proliferation of the HF epithelium (Figure 3C,D). Notably, the
number of proliferating cells in the upper HF epithelium was 3
times higher than in the HF bulb. This suggests that the
composition of aECM activated the outside-in signaling
mediated by β1 integrin and thus prolonged survival of the
embedded HF epithelium; moreover, this enhanced the
Figure 2.  β1 integrin silencing reduced significantly the epithelial progenitor protein expression in the hair follicle
bulge.  (A) Keratin 15 (K15) transcription was significantly reduced at day 4 by β1 integrin siRNA compared to the scrambled
control. (B) K15 immunoreactivity (IR) was most downregulated in β1 integrin siRNA silenced HFs in the upper HF (including the
bulge region), n=19-26 HFs of 3 individuals. (B1-3) Representative photos demonstrating the reference areas in the upper HF. (C)
β1 integrin silencing slightly enhanced the gene expression of CD200. (D) CD200 IR in the HF bulge was significantly reduced
compared to the scrambled control at day 4; n=17-28 HFs of 3 individuals. (D1-3) Representative photos which show the reference
areas in the upper HF. (E) β1 integrin knock down initially enhanced expression of K6, but reduced the transcription level
subsequently at day 4. (F) IR intensity of K6 in the different HF compartments. It demonstrated a non-specific repression of K6 IR in
every analyzed HF compartment by the silencing procedure as such, but not specifically by β1 integrin silencing. n=16-18 HFs of 2
individuals. (F1-3) Representative photos which show the reference areas in the upper HF. Fold expression of all analyzed genes
were normalized to GAPDH. n=2-3 individuals (for RNA extraction 12 HFs/patient were used and cultured over 4 days). IR intensity
of the HF bulb and the upper HF was measured with a specified rectangle with ImageJ (250x125). White scale bars
represent=100µm. All statistical analyses were performed with the one-way ANOVA by appropriate post hoc comparison
(depending on a given Gaussian distribution), mean of normalized data +/- SEM (*p<0.05, **p<0.01, ***p<0.001). Abbreviation:
HKG=housekeeping gene, GAPDH=glyceraldehyde 3-phosphate dehydrogenase, ITGβ1 KD=knock down of ß1 integrin, K=keratin,
IR=immunoreactivity.
doi: 10.1371/journal.pone.0084356.g002
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Figure 3.  β1 integrin receptor ligands differentially regulate vitality of keratinocytes in different hair follicle
compartments.  (A) Epithelial outgrowth area of outer root sheath keratinocytes (ORSKs) over 4 days was measured. While the
vehicle control hair follicles (HFs) showed no ORSK outgrowth in the culture dishes, the embedded HFs (aECM) showed a 30%
larger ORSK outgrowth area. Activating and inhibiting β1 integrin antibodies had very similar stimulatory effects on ORSK outgrowth
area. n=20-41 HFs of 3-4 individuals. Green lines and stars mark the significances of day2; black lines and stars mark the
significances of day4. Statistical analysis was performed with the Mann-Whitney test; mean+/-SEM (*p<0.05, **p<0.01, ***p<0.001).
(B) Representative photos of dispase-treated, embedded HF (aECM). Dotted line demarcates the area of analysis for the ORSK
outgrowth over the culture period of 4 days. Black scale bar=100µm. (C) Ki-67/TUNEL-staining demonstrated that β1 integrin
ligands, like extracellular matrix components and the specific receptor antibodies, decreased apoptosis in the upper HF, whereas in
the aECM and aECM+mAb13-treated group the proliferation rate is up-regulated, aECM+12G10 is similar to the vehicle control in
the HF bulb. n=7-15 HFs of 2-3 individuals. (D) Ki-67/TUNEL-staining confirmed the influence of β1 integrin ligands on HF bulb
cells. In the aECM and aECM+12G10-treated group the number of proliferative cells in the human HF bulb significantly increased.
The inhibiting antibody mAb13 enlarged apoptosis in HF bulb cells. n=8-16 HFs of 2-3 individuals. Statistical analyses of Ki-67/
TUNEL were performed with the one-way ANOVA by appropriate post hoc comparison (depending on a given Gaussian
distribution), error bars=mean of normalized data +/- SEM (*p<0.05, **p<0.01, ***p<0.001). Red bars=Ki-67, green bars=TUNEL. (E)
Cortactin revealed activated migration mainly in the HF bulb of the aECM-treated group. White scale bars=50µm. Abbreviation:
aECM=artificial ECM consisting of Matrigel®, collagen I and K-SFM (keratinocyte-serum free medium), aECM+12G10=aECM
supplemented with the activating β1 integrin antibody 12G10, aECM+mAb13=aECM supplemented with the inhibiting β1 integrin
antibody mAb13.
doi: 10.1371/journal.pone.0084356.g003
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proliferation rate in the HF bulge, the SC-rich and slow-cycling
HF compartment.
Testing, next, the effects of β1 integrin antibodies
incorporated into aECM showed that the ß1 integrin-stimulatory
antibody (12G10) significantly reduced apoptosis in the HF
bulb, and reduced proliferation in the upper HF compared to
the aECM group (Figure 3C,D). Instead, the ß1 integrin-
inhibitory antibody (mAb13) had the opposite effect and up-
regulated apoptosis, yet only in the hair bulb; unexpectedly, it
induced proliferation in the upper HF compartments including
the bulge (Figure 3C,D, Figure 4). These antibody stimulation
experiments suggest that distinct human ePCs in the HF show
a differential proliferation/apoptosis response in situ to ß1
integrin-mediated signaling.
The extracellular matrix environment stimulates hair
follicle keratinocyte migration primarily in the hair bulb
Besides proliferation and apoptosis, ORSK outgrowth is
likely to be dominated by ORSK migration events. This was
gauged by cortactin immunohistomorphometry, since activated
cortactin accumulates in actin-enriched lamellipodia and
membrane ruffles at the moving edge of migrating epithelial
cells, signifying a role in actin network formation [69].
The hair bulbs of dispase-pretreated and subsequently
aECM-embedded HFs showed strong activated cortactin IR,
which was prominently expressed in a larger number of FA-like
structures [70]. ORSKs showed enhanced migration into the
provided aECM. This may explain why the largest outgrowth of
ORSKs was measured around the HF bulb (Figure 3E)
Figure 4.  Schematic drawing for differential regulation via β1 integrin antibodies.  Comparison of the influences of activated
and inhibited signaling via β1 integrin specific antibodies on the protein expression of different immunoreactivity markers. The
immunoreactivity analyses of the β1 integrin-activating (12G10) or –inhibiting (mAb13) antibody-treated and aECM (artificial
extracellular matrix medium) embedded hair follicle (HF) epithelium suggested a different response of the epithelial progenitors cell
subpopulations on ß1 integrin signaling. The application of aECM-incorporated β1 integrin antibodies allowed distinguishing adult
human epithelial progenitor cell subpopulations with distinct amplifying capacities in situ, which are located in separate epithelial
compartments of human scalp HFs.
doi: 10.1371/journal.pone.0084356.g004
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although the highest proliferative (Ki-67+) capacity of ORSKs
was mainly seen in the upper HF (Figure 3C). Therefore, the
massive ORSK outgrowth seen in our CTS- and BM- mimicking
ECM system likely also enhanced ORSK migration in the
presence of ß1 integrin ligands.
Different human epithelial progenitor cell populations
differ in their dependence on β1 integrin signaling in
situ
To probe, next, whether β1 integrin-mediated signaling is
really needed for the maintenance and differentiation of ePCs
we checked the effects of β1 integrin knock down on the
expression of ePC markers K15 and CD200 [16,47,54,71] were
analyzed on the gene and protein expression level (Figure
S1A-F). For qRT-PCR the entire dispase-pretreated,
embedded and cultured HF epithelium was used. The upper
HF including the bulge showed that the HF-ECM mimicking
system significantly down-regulated the expression of the ePC
markers K15 and CD200 on the gene and protein level in
contrast to the vehicle control (dispase-pretreated HF
epithelium cultured without Matrigel®/collagen I) (Figure
S1A,B,D,E).
The dispase-pretreated HF epithelium embedded in aECM or
embedded and 12G10-treated showed a reduction of the
transcription level of K6 (Figure S1C), while the K6 IR pattern
demonstrated a strong differentiation-inducing capacity in the
whole HF epithelium (Figure S1F). Opposite results with regard
to K6 qRT-PCR and IR were obtained for the standard
denuded HF epithelium (vehicle control) compared to denuded,
aECM embedded and mAb13-treated HFs (Figure S1C,F).
Thus, although our CTS- and BM- mimicking ECM
components, which are expected to mimic endogenous β1
integrin ligands, optimize the survival of HF epithelium, the
same ligands reduce the ePC reservoir in the human HF bulge
and push this rapidly proliferating compartment of the HF
epithelium towards differentiation, as indicated by increased K6
protein expression.
Inhibiting or activating β1 integrin signaling
differentially stimulates human epithelial progenitor
cells and their progeny in distinct hair follicle
compartments
Since this had never been tested before in human epithelium
in situ, we also wanted to examine if anti-integrin antibodies
impact on β1 integrin transcription in adult human scalp HFs in
situ. qRT-PCR showed that the aECM-incorporated stimulatory
β1 integrin antibody (12G10) demonstrated no further
upregulation on day 4 in comparison to the aECM group
(Figure 5A). Instead, the inhibitory mAb13 antibody down-
regulated β1 integrin gene expression in human HFs in situ
(Figure 5A). This is the first demonstration of a direct
transcriptional effect of the inhibitory antibody on β1 integrin
gene expression in a human mini-organ.
Next, we tested whether distinct subpopulations of human
ePCs and their progeny in situ showed a differential response
pattern to the stimulation with antibodies that either stimulate or
inhibit ß1 integrin-mediated signaling [29,72–74]. Indeed, this
was the case. While the whole area outgrowth measurements
of the HFs did not show stimulatory or inhibitory differences
(Figure 3A), the proliferation and apoptosis analyses
demonstrated significant differences in the HF bulb and the
upper HF (Figure 3C,D). This was confirmed by corresponding
differences in ORSK largest outgrowth in these two defined HF
compartments (Figure 5C,D). While the ß1 integrin activating
antibody 12G10 enhanced ORSK largest outgrowth mainly in
the HF bulb (Figure 5D), interestingly and unexpectedly, in the
upper HF (including the bulge), epithelial cell largest outgrowth
was stimulated by the inhibitory antibody mAb13 (Figure 5C).
Moreover, studying expression of CD71 the activating antibody
12G10, but not the inhibitory mAb13, significantly enhanced
CD71 IR (and thus the number of transit amplifying cells) in
human HF bulbs (Figure 5B; see also Figure 4 and Text S2).
This suggests, dependent on the analysis method (area or
largest outgrowth) that inhibiting or activating β1 integrin
signaling elicits differential responses in adult human HF ePCs
compared to their more committed epithelial progeny.
QLT0267 impacts on β1 integrin-mediated signaling in
human hair follicle epithelium
As a first step towards dissecting the mechanisms by which
ß1 integrin-mediated signaling impacts on human ePCs and
their progeny in situ, we used the putative ILK inhibitor
QLT0267 [38,43] to probe the role of ILK. This cytoplasmic
adaptor protein of ß1 and ß3 integrin plays a key role in many
ß1 integrin-mediated cellular processes, including actin
rearrangement, cell adhesion, migration, proliferation,
apoptosis and differentiation by associating with different
regulatory proteins [40,75–78]. Since ILK protein expression
has not yet been demonstrated in human HFs, this was first
tested by Western blot. Indeed, human dispase-pretreated HF
epithelium expressed ILK protein as the expected 53kDa band
(Figure 6A).
Using QLT0267, we examined whether blocking ILK affected
human HFs in situ, focussing on ORSK survival and migration.
HF epithelium was embedded in aECM, supplemented with
100µM QLT0267. Already during HF culture it became evident
that approximately 40% of the aECM-embedded and QLT0267-
treated HFs lost their adhesion to the Matrigel®/collagen milieu
after 4 days of culture, a first overt evidence for massively
reduced ILK activity to create FAs. The reduction of ILK
expression via QLT0267 (100µM) was further documented by
analyzing ILK protein IR at day 4. Both in the HF bulb and in
the upper HF QLT0267 induced a significant reduction of ILK
IR (by 60-70%) (Figure 6D). Already 2 hours after QLT0267
incubation, the isolated HFs demonstrated a slightly reduction
in ILK IR (Figure S2D).
Furthermore, QLT0267 treatment also induced substantial
HF dystrophy, and almost abolished both ORSK outgrowth
(Figure 6B,C) as well as cortactin-activated migration (Figure
S3). This demonstrated that human ORSK migration in situ and
F-actin cytoskeleton remodelling [77] critically depend on ILK-
mediated signaling via a Src activation of proteins like cortactin,
which is mandatory for their phosphorylation and thereby for
actin assembly [79].
Moreover, DAPI staining revealed numerous pyknotic nuclei
in the HF epithelium indicating the high level of HF dystrophy
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and apoptosis induced by QLT0267 treatment (data not
shown). This was confirmed by quantitative
immunohistomorphometry for cleaved caspase 3 (Figure 6E),
TUNEL and Ki-67, which documented massive intraepithelial
apoptosis and cessation of ORSK proliferation (Figure S2E).
Therefore, pharmacological inhibition of ILK likely induced
anoikis, i.e. cell death due to a loss of connection with the ECM
or adjacent cells [80,81], thereby destroying the entire ORS.
In summary, our studies provide the first evidence in a
human complex system that ILK-dependent β1 integrin-
mediated signaling is mandatory for the adhesion of basal layer
ORSK to the ECM thus stabilizing cell-ECM connection via FAs
as well as promoting survival of human HF epithelium.
Discussion
Most data on the function of β1 integrin-mediated signaling in
ePCs and their interaction with the ECM are based on murine
models [82–85] or cell culture experiments [66,86,87].
However, the role of β1 integrin-mediated signaling in human
ePCs growing within their natural tissue habitat had been
largely unknown. Using organ-cultured human scalp HFs as a
clinically relevant model for studying human ePCs in situ, we
Figure 5.  β1 integrin-mediated signaling stimulated different epithelial progenitor cell populations in distinct hair follicle
compartments.  (A) Relative gene expression of β1 integrin. The β1 integrin-activating antibody 12G10 did not alter β1 integrin
gene expression, whereas the inhibition of the receptor via mAb13 significantly reduced β1 integrin expression. n=1-2 individuals in
experimental triplicates (15 hair follicles [HFs]). (B) Immunoreactivity of CD71 enabled to distinguish between different epithelial
progenitor cell populations within the HF bulge and the HF bulb. n=5-10 HFs of 3-4 individuals. The data were analysed by using the
one-way ANOVA with the appropriate post hoc comparison (depending on a given Gaussian distribution), mean of normalized data
+/- SEM (*p<0.05, **p<0.01, ***p<0.001). (C) Measurement of the largest outgrowth in the upper HF and (D) HF bulb over 4 days
displayed the large influence of the β1 integrin antibody treatment and distinguished between the different epithelial progenitor cell
populations via their response to β1 integrin antibody stimulation. In the upper HF region (including the bulge) the inhibiting β1
integrin antibody mAb13 significantly stimulated epithelial outgrowth, whereas in the HF bulb the activating antibody 12G10 antibody
stimulated epithelial outgrowth. Photos show dispase-pretreated upper HFs and HF bulbs after embedding into the aECM (artificial
extracellular matrix) system and treating with β1 integrin antibodies at day 4. White lines demarcate the reference areas. n=18-33
HFs of 4 individuals. Mean+/-SEM, using unpaired t-test (*p<0.05, **p<0.01, ***p<0.001). Scale bars: 100µm. Abbreviation:
aECM=artificial ECM consisting of Matrigel®, collagen I and K-SFM (keratinocyte-serum free medium), aECM+12G10=aECM
supplemented with the activating β1 integrin antibody 12G10, aECM+mAb13=aECM supplemented with the inhibiting β1 integrin
antibody mAb13, HKG=housekeeping gene, PPIA=peptidylprolyl isomerase A, IR = immunoreactivity.
doi: 10.1371/journal.pone.0084356.g005
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show here that β1 integrin signaling controls survival, adhesion,
and migration in distinct ORS populations, including human HF
eSCs and their progeny. Moreover, our data suggest that ß1
integrin signaling is fundamental for maintenance of the HF
bulge eSC niche, while different human HF ePC
subpopulations differ in their response to ß1 integrin signaling.
The examined HF effects of ß1 integrin signaling are ILK-
dependent.
Though our method of siRNA β1 integrin silencing was
functionally effective and was documented on the mRNA level,
we could not detect any change in the protein level 4 days after
transfection. While the half-life of integrins on the surface of
cultured human keratinocytes in vitro reportedly is about 12 h
[88], their half-life in situ and in vivo is much longer. For
example, in murine epidermis, β1 integrin can still be detected
in vivo 10 days after Cre activation and in some HFs β1 integrin
Figure 6.  Integrin-linked kinase inhibition via QLT0267 stops the epithelial outgrowth.  (A) Integrin-linked kinase (ILK) is
expressed in human dispase-pretreated HF (hair follicle) keratinocytes, which was demonstrated by using the Western blot method
in comparison to the protein expression of β-actin. (B) The analysis of the largest outgrowth in the HF bulb and (C) in the upper HF
revealed the strong inhibitory effect of the pharmacological substance QLT0267 for the proliferative and migrative capacity.
Representative photos. n=24-28 HFs of 3 individuals. (D) In the HF bulb and in the upper HF a significant reduction of ILK
immunoreactivity could be demonstrated with QLT0267 treatment in comparison to our control HFs, which were dispase-pretreated
and embedded in the artificial extracellular matrix with DMSO. Representative photos show the reference areas in the upper HF,
n=7-10 HFs of 3 individuals. (E) The QLT0267 treatment caused a tremendous apoptotic effect in the HF epithelium, showing by
nearly 100% cleaved caspase 3+ outer root sheath keratinocytes. n=5-10 HFs of 3 individuals. For each immunoreactivity intensity
analysis the control was normalized to 100%. White scale bars=50µm. All statistical analyses were done by using Mann-Whitney
test, (*p<0.05, **p < 0.01, ***p < 0.001); mean+/-SEM. Abbreviation: aECM+DMSO=artificial ECM consisting of Matrigel®, collagen I
and K-SFM (keratinocyte-serum free medium), aECM+QLT0267=aECM supplemented with the 100µM pharmacological inhibitor
QLT0267, DMSO=Dimethyl sulfoxide, ILK=integrin-linked kinase, IR=immunoreactivity.
doi: 10.1371/journal.pone.0084356.g006
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IR is even visible after 1-2 weeks [3,89]. This likely explains the
discrepancy of our mRNA and protein results after knock down.
That β1 integrin might be needed as a niche receptor for
regulating proliferation activity in distinct ePC populations in the
HF bulb and bulge is in line with neonatal K5Cre β1 null-mice
showing HF and sebaceous gland loss, and greatly reduced
proliferation [89]. The current silencing results also are in line
with our previous finding that the stimulation of ß1 integrin-
mediated signaling enhances the proliferation of hair matrix
keratinocytes in organ-cultured human HFs, using the ß1
integrin-activating antibody 12G10 [29].
K15 and CD200 are well accepted as ePC markers of the HF
bulge [16,20,23,54,90], but whether the expression of these
markers is ß1 integrin-dependent remains unclear. The current
knock down data now clarify that ß1 integrin signaling is
necessary for keeping human ePCs in an undifferentiated state
in situ, i.e. for maintenance of K15+ and CD200+ ORSKs in the
HF bulge.
The role of β1 integrin in the maintenance of eSCs or ePCs
is still controversially discussed. Jones and Watt proposed a
role of β1 integrin signaling for the maintenance of human skin
eSCs in vitro, because these cells expressed high levels of β1
integrin and showed typical SC properties like high CFE [28]. In
contrast, a direct link between the loss of β1 integrin skin-
specific conditional knock out to an ePC or eSC reduction
could not be elucidated in mutant mice [84], and ß1 integrin
protein levels in situ are not markedly higher in the human
bulge than elsewhere in the human ORS [29]. However, here
we show that β1 integrin silencing impacts on K15 and CD200
expression in a complex human mini-organ, the HF suggesting
that β1 integrin-mediated signaling is indeed required for ePC
maintenance in adult human HFs.
Since the human bulge likely represents an immunologically
privileged SC niche [91], it is interesting that ß1 integrin
silencing also reduces HF bulge expression of the
immunoinhibitory “no danger”-signal, CD200. Future functional
experiments, therefore, will need to clarify whether this reduced
CD200 expression compromises the relative HF bulge immune
privilege in human HFs. Clinically, this may be relevant for
irreversible forms of human hair loss characterized by a loss of
K15+/CD200+ bulge cells and a collapse of the HF bulge
immune privilege [91], like the cicatricial alopecia, lichen
planopilaris [61], where insufficient ß1 integrin-mediated
signaling may contribute to the CD200-dependent component
of the HF bulge immune privilege collapse demonstrated in this
scarring hair loss disorder [91].
For the direct manipulation of β1 integrin-mediated signaling
in ePC populations of the HF epithelium removal of the HFs
BM and CTS by dispase appeared necessary. This, however,
artificially disrupts cell-ECM connections and greatly
dysregulates the surrounding ECM environment, likely inducing
a broad range of abnormalities [92]. Under our HF organ
culture conditions, this unphysiological culture of denuded HF
epithelium is further compounded by the absence of serum
components such that may promote ß1 integrin signaling, thus
severely compromising the normal conditions for outgrowth and
survival of the HF epithelium. To optimize this defective ECM
environment, we used only Matrigel® for embedding the HF
epithelium, guided by previous work [93]. However, after
several days, most HFs lost their adhesion to the provided
surrogate matrix. This might result from the activity of enzymes
like matrix metalloproteinase (MMPs) which are expressed in
HFs for degrading ECM components and by this contribute to
HF growth and cycling [94,95]. But such enzymes require a
physiological balance between their activity and their specific
inhibitors for a controlled function [94]. Adding collagen I to
Matrigel® (1:1) apparently mimicked the lost ECM signals
arisen from the HFs CTS and BM, and enabled human HF
ORSK outgrowth in situ and ORSK emigration.
The opposite effects on proliferation and apoptosis in the HF
bulb and bulge, but also the reduction of the ePC markers K15
and CD200 in these embedded HFs, confirm the widely
appreciated effect of Matrigel® as a stimulator of proliferation
and differentiation [96]. Thus, this mouse sarcoma derived
matrix is not an optimal surrogate of the HF ECM for mimicking
the human SC niche in situ and for keeping human ePCs in an
undifferentiated state. Therefore, better-defined human-derived
alternative ECM composites are urgently needed [97,98].
Interestingly, inhibiting or activating β1 integrin signaling
modulates the functions of human ePCs and their progeny in a
highly differential manner, depending on where these cells are
located within the HF epithelium. This obvious difference could
not be shown measuring the whole outgrowth area of the HF
(Figure 3A) while the more specific analysis methods of the
largest outgrowth and the proliferation/apoptosis of defined HF
compartments (Figure 3C,D and Figure 5C,D), revealed the
different antibody effects. These specific differences are
possibly due to the functionally different cells types located in
these compartments, namely ePCs in the HF bulge versus
transit amplifying cells in the HF bulb. These findings also fit
well to the analysis of the different proliferation and apoptosis
potential in the bulb and the upper HF bulge.
The activating β1 integrin antibody (12G10) induces
proliferation and differentiation in the HF bulb whereas the
inhibiting β1 integrin antibody (mAb13) keeps the ePCs in a
more undifferentiated state. But the opposite effects were
shown on the more distal located HF compartment the upper
HF including the bulge (see Figure 4 for details). Our results
obtained with manipulating β1 integrin activity via specific
activating and inhibiting antibodies arose new functions for their
usage and invite the hypothesis that β1 integrin receptor-
mediated signaling in HF matrix cells primarily regulates and
stimulates the proliferative capacity and differentiation of the
HF. In contrast, β1 integrin signaling in the eSC niche (HF
bulge) appears to operate as quiescence signal by outside-in
signaling via the surrounding ECM. By using the inhibiting
antibody mAb13 this β1 integrin-mediated signaling in the hair
matrix cells was changed followed by a tremendous apoptosis,
whereas the proliferation quiescence function in the HF bulge
altered which lead to an increased Ki-67+ cell number.
We postulate that the different antibodies are useful markers
to distinguish between ePCs in the bulge and transit amplifying
cells in the bulb, which are known to have different proliferation
capacities. While the transit amplifying cells of the HF bulb are
highly active cells for reproducing/maintenance the HF, the
ePCs of the HF bulge represent a slow cycling and quiescent
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ORSK population. Changes of the β1 integrin-mediated
signaling in these HF compartments, for example by using of
mAb13, lead to a disturbed outside-in signaling reaction.
Consequently, mAb13 pushed the proliferating active transit
amplifying cells into apoptosis, while the slow-cycling ePCs in
the HF bulge did not change their status of activity. This novel
finding shows that using these specific β1 integrin antibodies
initiates different reactions of ePCs in the bulge and in the bulb.
The manipulation of the β1 integrin-mediated signaling certainly
appears to be one of the means by which the surrounding ECM
profoundly and differentially modulates epithelial cell behavior
in human HFs.
The manipulation of the β1 integrin-mediated signaling
certainly appears to be one of the means by which the
surrounding ECM profoundly and differentially modulates
epithelial cell behavior in human HFs.
It is controversially debated whether ILK really is a true
kinase or just a scaffolding protein [76,99–102] and it has been
questioned how the pharmacological inhibitor QLT0267 really
works, which was developed to inhibit ATP binding of ILK [44].
Until now the role of ILK in cellular processes has been studied
in transformed and/or tumorigenic cells [37,38,103], and in
mouse models [39,78,104], but not in a complex human mini-
organ. By using our experimental setup an efficient reduction of
ILK expression in situ via QLT0276, the potent apoptosis-
inducing capacity [37,38] and the loss of adhesion (abrogates
ORSK migration) was striking in pharmacologically ILK-
blockaded human HFs (Figure 6, Figure S2E). Former studies
with this pharmacological inhibitor also demonstrated an
effective reduction of ILK activity as well as a decrease of AKT
(AKT kinase) and FAK (focal adhesion kinase) phosphorylation
in tumor cell lines [36,38,44].
Importantly, our human HF organ culture data are in line with
the results obtained in ILK-K5 knock out mice concerning the
impaired directional migration followed by a missing forming of
stable lamellipodia-like structures, as well as the detachment
through the surrounding environment [105]. Thus, the high
level of ORSK apoptosis could be caused by missing AKT
phosphorylation after QLT0267 treatment, as previously
described in a tumor cell line [41] or the impaired formation of
FA because of a reduced ILK expression [106,107].
Irrespective of this consideration, our data suggest that ILK
protein is functionally important for β1 integrin-mediated
signaling in the human HF and for the survival of human
ORSKs.
Taken together, our study demonstrates that ePCs in human
HFs require β1 integrin-mediated signaling for survival,
adhesion, and migration, and that different human HF ePC
subpopulations differ in their response to β1 integrin signaling.
Mechanistically, this effect is likely ILK-dependent. These new
insights into the β1 integrin-dependence of distinct human ePC
populations enrich our as yet very fragmentary understanding
of the integrin-dependent topobiology of human ePCs in situ,
and are relevant for cell-based regenerative medicine
strategies that employ HF-derived ePCs [90,108].
Supporting Information
Figure S1.  Differentiation of epithelial progenitor cells is
regulated by β1 integrin ligands. (A) Embedding into the
niche mimicking aECM (artificial extracellular matrix) system
significantly downregulated the gene expression of the HF (hair
follicle) progenitor marker Keratin 15 (K15). The β1 integrin
inhibiting antibody mAb13 increased the K15 transcription.
(B) Embedding into the aECM system β1 integrin antibodies
significantly reduced the gene expression of CD200. (C) The
Keratin 6 (K6) transcription was strongly repressed in the
aECM and aECM+12G10-treated group, while this reduction is
not so high in the mAb13-treated group. n=1 (2) individuals in
experimental triplicates (12-15 HFs). (D) Immunoreactivity of
K15 was only found in the upper HF including the bulge. By
counting K15+ cells in a specified area (250x125) the decrease
of this progenitor marker was measurable. n=7-15 HFs of 3-4
individuals. (E) CD200+ cells were also only found in the upper
HF including the bulge. The CD200+ cells were counted in a
specified area (250x125) and confirmed the gene expression
results of this progenitor marker. n=7-10 HFs of 2-3 individuals.
(F) The immunoreactivity expression pattern of K6 was
analysed in the HF bulb, lower HF and upper HF by
quantitative immunohistochemistry in fixed rectangle. The
supplementation of the inhibitory antibody mAb13 reduced the
differentiation inducing capacity of the artificial ECM system in
the whole HF. n=4-7 HFs of 3 individuals. White scale bars in
the representative photos=100µm. All data were analysed by
using the One way ANOVA, Bonferroni post hoc test, mean +/-
SEM (*p<0.05, **p<0.01, ***p<0.001). Abbreviation: aECM =
artificial ECM consisting of Matrigel®, collagen I and K-SFM
(keratinocyte-serum free medium), aECM+12G10=aECM
supplemented with the activating β1 integrin antibody 12G10,
aECM+mAb13=aECM supplemented with the inhibiting β1
integrin antibody mAb13, HKG=housekeeping gene,
PPIA=peptidylprolyl isomerase A.
(TIF)
Figure S2.  β1 intergin knock down and the inhibition via
QLT0267. (A) The knock down of β1 integrin did not alter the
CD71 immunoreactivity (IR) expression in the HFs. n=11-18-
HFs of 2 individuals. (B) MHC Ia IR intensity demonstrated that
the silencing reaction and the specific knock down of ITGβ1
had no influence on the immune privilege of the HF bulge.
n=12-19 HFs of 2 individuals. (C) Representative photos of the
EdU IR of scrambled control and ITGβ1 KD HFs are shown.
(D) Intergin-linked kinase (ILK) IR intensity in human HFs after
2h incubation in 37°C with or without QLT0267 before
embedding into the artificial extracellular matrix demonstrated
the fast reduction/inhibiton of ILK in outer root sheath
keratinocytes. (E) Ki-67/TUNEL-staining confirmed the caspase
3 staining, while the QLT0267-treated HFs showed no
proliferation, but a high apoptosis rate in comparison to the
DMSO-treated control. Red bars=Ki-67, green bars=TUNEL.
n=7-12 HFs of 3 individuals. For each analysis of the IR
intensity the control was normalized to 100%. White scale
bars=50µm. All statistical analyses were done by using Mann-
Whitney test, (***p<0.001), mean +/- SEM. Abbreviation: ITGβ1
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KD = β1 integrin knock down, MHC Ia = major
histocompatibility complex (MHC) class Ia.
(TIF)
Figure S3.  Integrin-linked kinase inhibition via QLT0267
inhibits keratinocyte migration. The cortactin
immunoreactivity was nearly absent in the aECM+QLT0267-
treated HFs compared to the aECM+DMSO-treated group on
day 4. This demonstrated that human outer root sheath
keratinocyte migration in situ and F-actin cytoskeleton
remodelling [76] depend on integrin-linked kinase (ILK)-
mediated signalling via a Src (Proto-oncogene tyrosine-protein
kinase) activation of proteins like cortactin. Abbreviation: aECM
+DMSO=artificial ECM consisting of Matrigel®, collagen I and
K-SFM (keratinocyte-serum free medium), aECM
+QLT0267=aECM supplemented with the 100µM
pharmacological inhibitor QLT0267, DMSO=Dimethyl sulfoxide.
(TIF)
Text S1.  (DOC)
Text S2.  (DOC)
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